| David S Gendelman, MD | |
|
172 Cambridge Street, Burlington, MA 01803 | |
| (781) 272-4944 | |
| (781) 272-8756 |
| Full Name | David S Gendelman |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 43 Years |
| Location | 172 Cambridge Street, Burlington, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730186818 | NPI | - | NPPES |
| GEJ04746 | Other | BCBS OF CONNECTICUT | |
| GEJ04746 | Other | BCBC OF ILLINOIS | |
| 8180 | Other | CIGNA HEALTHSOURCE | |
| GEJ04746 | Other | BCBS OF OREGON | |
| GEJ04746 | Other | BCBS OF PENNSYLVANIA | |
| GEJ04746 | Other | BLUE SHIELD | |
| GEJ04746 | Other | BCBS PPO | |
| 0800236 | Other | UNITED HEALTHCARE | |
| 15316 | Other | HARVARD COMM HEALTH | |
| 3001067 | Medicaid | MA | |
| CE5062 | Other | RAILROAD MEDICARE | |
| GEJ04746 | Other | BCBS | |
| 991743 | Other | NETWORK HEALTH | |
| 108 | Other | SECURE HORIZONS NEEC | |
| GEJ04746 | Other | BCBS OF MA | |
| 043070848015 | Other | BCBS | |
| GEJ04746 | Other | EMPIRE BCBS | |
| GEJ04746 | Other | REGENCE BLUE SHIELD | |
| GEJ04746 | Other | HORIZON BCBS OF NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 55101 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Associates Pc | 6002836079 | 8 |
| Boston Laser Eye Institute Pc | 9739123381 | 22 |
News Archive
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common -"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.
The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.
› Verified 6 days ago
| Entity Name | Boston Laser Eye Institute Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053496497 PECOS PAC ID: 9739123381 Enrollment ID: O20050614001090 |
News Archive
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common -"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.
The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.
› Verified 6 days ago
| Entity Name | Eye Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790789741 PECOS PAC ID: 6002836079 Enrollment ID: O20051206000274 |
News Archive
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common -"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.
The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David S Gendelman, MD 172 Cambridge Street, Burlington, MA 01803 Ph: (617) 202-2020 | David S Gendelman, MD 172 Cambridge Street, Burlington, MA 01803 Ph: (781) 272-4944 |
News Archive
Scientists in the United States have found that stem cell transplants enabled people with type 1 diabetes to manage for as long as four years without needing insulin injections and to maintain good glycemic control - such patients typically need daily insulin therapy to control their diabetes.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common -"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.
The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases, according to a study by Johns Hopkins' Wilmer Eye Institute.
› Verified 6 days ago
Dr. Paul R Cotran, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 Fax: 781-744-5215 | |
Dr. Jeffrey Chang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8555 | |
Kendra Klein-mascia, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8000 Fax: 781-744-2540 | |
Amer M Alwreikat, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 978-558-4440 Fax: 978-538-4721 | |
Dr. Justin David Pennington, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Megan Nichols, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8555 Fax: 781-744-5243 | |
Carolyn Anderson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-5100 Fax: 781-744-5215 |